Cargando…

The Tolerability of Mirtazapine Augmentation in Schizophrenic Patients Treated with Risperidone: A Preliminary Randomized Placebo-controlled Trial

OBJECTIVE: Some patients with schizophrenia may need mirtazapine augmentation to improve negative and cognitive symptoms. However there have been a few studies about the tolerability of mirtazapine augmentation to antipsychotics such as akathisia, extrapyramydal symptoms, weight gain, and body mass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jieun, Cho, Sung Joon, Lee, Kang Soo, Yook, Keunyoung, Choe, Ah Young, Lee, Sungjae, Kim, Borah, Kim, Keung-Hyang, Choi, Tae Kyou, Lee, Sang-Hyuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569079/ https://www.ncbi.nlm.nih.gov/pubmed/23431108 http://dx.doi.org/10.9758/cpn.2011.9.2.73

Ejemplares similares

Mirtazapine/risperidone/warfarin: Ischaemic priapism: case report
Publicado: (2022)

Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2007)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Efficacy and safety of once-monthly Risperidone ISM(®) in schizophrenic patients with an acute exacerbation
por: Correll, Christoph U., et al.
Publicado: (2020)

Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary Evidence
por: Hendouei, Narjes, et al.
Publicado: (2016)

Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population
por: Almoguera, B, et al.
Publicado: (2013)

Risperidone-Induced Neutropenia in a Schizophrenic Patient: A Case Report and Literature Review
por: Atolagbe, Ayodele, et al.
Publicado: (2021)

Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2008)

Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report
por: Theleritis, Christos G, et al.
Publicado: (2006)

The Comparison of Olanzapine and Risperidone Treatment in Male Schizophrenic Patients using Positive and Negative Syndromes Scale (PANSS)
por: Lestari, Endah Tri, et al.
Publicado: (2018)

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
por: Sahlsten Schölin, Johan, et al.
Publicado: (2023)

Unmasking of Myasthenia Gravis After Introduction of Oral Risperidone in a Schizophrenic Saudi Male: A Case Report
por: Abualkhair, Lamees, et al.
Publicado: (2021)

The Effects of 5-HTR1A Polymorphism on Cingulum Connectivity in Patients with Panic Disorder
por: Yu, Seung Taek, et al.
Publicado: (2013)

Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
por: Banerjee, Sube, et al.
Publicado: (2021)

Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019)

Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2017)

The Prevalence of Metabolic Syndrome in Schizophrenic Patients Using Antipsychotics
por: Ko, You-Kyung, et al.
Publicado: (2013)

Mirtazapine Augmentation for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: A Retropective Investigation
por: Atmaca, Murad, et al.
Publicado: (2011)

Mirtazapine withdrawal-induced mania
por: Verma, Jitendra Kumar, et al.
Publicado: (2015)

Tachyphylaxis to the Sedative Action of Mirtazapine
por: Papazisis, Georgios, et al.
Publicado: (2018)

Mirtazapine for the Treatment of Chronic Pruritus
por: Khanna, Raveena, et al.
Publicado: (2019)

Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020)

Risperidone and fluvoxamine; two directions of augmentation: a case report
por: Štracak, M., et al.
Publicado: (2023)

REHABILITATION NEEDS OF SCHIZOPHRENIC PATIENTS - A PRELIMINARY REPORT
por: Nagaswami, Vijay, et al.
Publicado: (1985)

PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016)

ACUTE SCHIZOPHRENIC EPISODES—ARE THEY SCHIZOPHRENIC?
por: Singh, Gurmeet, et al.
Publicado: (1981)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Mirtazapine Treatment of a Severe Depressive Episode and Resolution of Elevated Inflammatory Markers
por: Alikhan, Shahzad M., et al.
Publicado: (2013)

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France
por: Limosin, Frédéric, et al.
Publicado: (2018)

PS88. Association between Alu insertion/deletion polymorphism on the tPA gene and mirtazapine response in Koreans with major depression
por: Kim, Daseul, et al.
Publicado: (2016)

Mirtazapine-associated hyponatremia presenting as delirium
por: Ghosh, Abhishek, et al.
Publicado: (2014)

Mirtazapine-induced acute angle closure
por: Kahraman, Nilay, et al.
Publicado: (2015)

Mirtazapine for symptom control in refractory gastroparesis
por: Malamood, Mark, et al.
Publicado: (2017)

Nightmares with mirtazapine - A case report
por: Kavoor, Anjana Rao, et al.
Publicado: (2020)

A Case of Mirtazapine-Induced Pancreatitis
por: Aslam, Hunain, et al.
Publicado: (2023)

Mirtazapine-induced hyperpigmentation with type II histopathologic findings
por: Sukhdeo, Kumar, et al.
Publicado: (2018)

Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2009)

Serotonin Transporter and COMT Polymorphisms as Independent Predictors of Health-related Quality of Life in Patients with Panic Disorder
por: Kang, Eunho, et al.
Publicado: (2016)

Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial
por: Ostenfeld, Anne, et al.
Publicado: (2020)

Neurotoxic Syndrome Developed after Taking Sertraline and Risperidone
por: Kim, Jeong-Min, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_piokhghsl9gncnuq4pvc4duviu